resorcinol has been researched along with Encephalopathy, Toxic in 1 studies
resorcinol: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7951
resorcinol : A benzenediol that is benzene dihydroxylated at positions 1 and 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Resorcinol's potency to inhibit TPO was profoundly lower than that of PTU or MMI." | 2.53 | A comparison of potency differences among thyroid peroxidase (TPO) inhibitors to induce developmental toxicity and other thyroid gland-linked toxicities in humans and rats. ( Motonaga, K; Odawara, K; Ota, M; Saito, S; Welsch, F, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Motonaga, K | 1 |
| Ota, M | 1 |
| Odawara, K | 1 |
| Saito, S | 1 |
| Welsch, F | 1 |
1 review available for resorcinol and Encephalopathy, Toxic
| Article | Year |
|---|---|
A comparison of potency differences among thyroid peroxidase (TPO) inhibitors to induce developmental toxicity and other thyroid gland-linked toxicities in humans and rats.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Autoantigens; Biomarkers; Dose-Response | 2016 |